La tuberculosis constituye un problema de salud importante en todo el mundo. Este trabajo se centró en tres áreas de la enfermedad sobre las que todavía se desconocen muchos aspectos: (i) los factores que influyen en el tiempo transcurrido desde la siembra de las muestras hasta la detección de M.tuberculosis complex en el cultivo (TTD), (ii)...
-
April 26, 2018 (v1)PublicationUploaded on: March 27, 2023
-
March 31, 2020 (v1)Publication
Introduction: The rapid worldwide spread of carbapenem-resistant Enterobacteriaceae (CRE) constitutes a major challenge. The aim of the EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA), which is part of the Innovative Medicines Initiative Joint Undertaking (IMI JU) funded COMBACTE-CARE...
Uploaded on: December 4, 2022 -
February 1, 2023 (v1)Publication
Objectives: To describe the population pharmacokinetics of fosfomycin for patients with bacteraemic urinary tract infection (BUTI). The analysis identified optimal regimens on the basis of pharmacodynamic targets and assessed the adequacy of Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial...
Uploaded on: March 1, 2023 -
May 16, 2017 (v1)Publication
Introduction Finding therapeutic alternatives to carbapenems in infections caused by extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC) is imperative. Although fosfomycin was discovered more than 40 years ago, it was not investigated in accordance with current standards and so is not used in clinical practice except in...
Uploaded on: March 25, 2023 -
September 30, 2022 (v1)Publication
Importance The consumption of broad-spectrum drugs has increased as a consequence of the spread of multidrug-resistant (MDR) Escherichia coli. Finding alternatives for these infections is critical, for which some neglected drugs may be an option. Objective To determine whether fosfomycin is noninferior to ceftriaxone or meropenem in the...
Uploaded on: December 2, 2022